Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Neoplasms 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Prostate Cancer Metastatic 1Ovarian Neoplasms 1Neutropenia 1Lymphoma, B-Cell 1Hodgkin Disease 1Endodermal Sinus Tumor 1Central Nervous System Neoplasms 1Castrate Resistant Prostate Cancer 1

Interventions

pegfilgrastim 30Filgrastim 29Cyclophosphamide 10Docetaxel 8pegylated granulocyte colony-stimulating factor 7Etoposide 7Cytarabine 7Ciprofloxacin 5Cefepime 5eflapegrastim 4Vancomycin 4Leucovorin 4Granulocyte Colony-Stimulating Factor 4Fluorouracil 4Doxorubicin 4Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Methotrexate 3Levofloxacin 3Irinotecan 3Idarubicin 3Daunorubicin 3Cyclosporine 3Caspofungin 3Carboplatin 3trifluridine tipiracil drug combination 2plerixafor 2liposomal amphotericin B 2Vincristine 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neutropenia × Lenograstim × Clear all
NCT06145321 2024-09-19

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Chang Gung Memorial Hospital

Phase 4 Active not recruiting
20 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡